Skip to main content
. 2017 Jul 20;12(7):e0180986. doi: 10.1371/journal.pone.0180986

Table 3. Published RCTs that were registered before or during trial completion and have major discrepancies with their trial registries and the effect of these discrepancies on the statistical significance of published outcomes, by funding source.

Total Annals of Neurology Lancet Neurology Neurology
Number of published RCTs 180 12 82 86
Number of published RCTs with major discrepancies between registry and publication 87 (48%) 9 (75%) 29 (35%) 52 (60%)
Number of major discrepancies between registry and publication 180 19 55 106
Registered primary outcomes demoted in publication 10 (6%) 4 (21%) 2 (4%) 4 (4%)
Registered primary outcomes omitted from publication 38 (21%) 5 (26%) 16 (29%) 17 (16%)
Unregistered primary outcomes added to publication 61 (34%) 2 (11%) 18 (33%) 41 (39%)
Registered secondary outcomes promoted in publication 18 (10%) 1 (5%) 4 (7%) 13 (12%)
Timing of assessment of primary outcomes differs 53 (29%) 7 (37%) 15 (27%) 31 (29%)
Number of major discrepancies between registry and publication 180 19 55 106
Did not report p-values 7 (4%) 2 (11%) 3 (5%) 2 (2%)
Reported p-values 82 (46%) 5 (26%) 21 (38%) 56 (53%)
Major discrepancy favors statistical significance 52 (63%) 3 (60%) 14 (67%) 38 (68%)
Major discrepancy does not favor statistical significance 33 (40%) 2 (40%) 7 (33%) 18 (32%)
Number of RCTs containing major discrepancies favoring statistical significance 38 3 10 25